MedicX Fund (LSE: MXF), the specialist primary care infrastructure investor in modern, purpose-built, primary healthcare properties in the United Kingdom, announces that today, Wednesday 8 August 2012, it sold for cash 2,000,000 ordinary shares of no par value in the Company. The ordinary shares were sold out of treasury by the Company, at a price per share (before expenses) of 77.5 pence.
The net proceeds will be used in further pursuing the investment objectives of the Company.
Following this transaction, the Company has 263,645,780 ordinary shares in issue, of which 4,779,564 are held in treasury. Accordingly, the total voting rights in issue will be 258,866,216.
For further information please contact:
MedicX Group: +44 (0) 1483 869 500
Keith Maddin, Chairman
Mike Adams, Chief Executive Officer
Mark Osmond, Chief Financial Officer
Canaccord Genuity Limited: +44 (0) 20 7523 8000
Andrew Zychowski/Helen Goldsmith
Buchanan: +44 (0) 20 7466 5000
Charles Ryland/Gabriella Clinkard
MedicX Fund: +44 (0) 1481 723 450
David Staples, Chairman
Information on MedicX Fund Limited
MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 106 properties.
The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 29 people operating across the UK.
The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website),nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.
This information is provided by RNS
The company news service from the London Stock Exchange
Datafeed and UK data supplied by NETbuilder and Interactive Data.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.